Scopus BioPharma Ownership 2024 | Who Owns Scopus BioPharma Now?
Institutional Ownership
0.36%
Insider Ownership
18.69%
Retail Ownership
80.95%
Institutional Holders
1.00
Scopus BioPharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M&R CAPITAL MANAGEMENT INC | - | - | - | -76,819 | -100.00% | - | Mar 31, 2023 |
Scopus BioPharma's largest institutional shareholder is M&R CAPITAL MANAGEMENT INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M&R CAPITAL MANAGEMENT INC | - | - | - | -76,819 | -100.00% | - | Mar 31, 2023 |
The largest Scopus BioPharma shareholder by % of total assets is M&R CAPITAL MANAGEMENT INC. The company owns 0.00 shares of Scopus BioPharma (SCPS), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M&R CAPITAL MANAGEMENT INC | - | - | - | -76,819 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Scopus BioPharma's largest institutional buyer is M&R CAPITAL MANAGEMENT INC. The company purchased -76.82K stocks of SCPS, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M&R CAPITAL MANAGEMENT INC | - | - | - | -76,819 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Scopus BioPharma's biggest institutional seller is M&R CAPITAL MANAGEMENT INC. The company sold -76.82K shares of SCPS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M&R CAPITAL MANAGEMENT INC | - | - | - | -76,819 | -100.00% | - | Mar 31, 2023 |
Scopus BioPharma's largest sold out institutional shareholder by shares sold is M&R CAPITAL MANAGEMENT INC, sold -76.82K shares, valued at -, as of undefined.
Scopus BioPharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.01% | 32,966 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 924 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 214,201 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 6,024 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 11,810 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 87,334 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 450 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 4,044 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,000 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 52,189 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 120 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 2,632 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 9,214 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 15,824 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,566 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 866 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 495 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 54 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 600 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 4,166 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 1,268 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 715 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 811 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 1,640 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,112 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 2,806 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,082 | - | - | Feb 29, 2024 |
Scopus BioPharma's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 32.97K shares, compromising 0.01% of its total assets.
Scopus BioPharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 22 | 1 | -91.67% |
| 30 Sep, 22 | 12 | -7.69% |
| 30 Jun, 22 | 13 | -23.53% |
| 31 Mar, 22 | 17 | -15.00% |
| 31 Dec, 21 | 20 | 81.82% |
| 30 Sep, 21 | 11 | -8.33% |
| 30 Jun, 21 | 12 | -57.14% |
| 31 Mar, 21 | 28 | 600.00% |
| 31 Dec, 20 | 4 | - |
As of 31 Dec 22, 1 institutions are holding Scopus BioPharma's shares, representing a decrease of -91.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 22 | 76,819 | -83.47% |
| 30 Sep, 22 | 464,786 | -32.10% |
| 30 Jun, 22 | 684,494 | -32.12% |
| 31 Mar, 22 | 1,008,382 | -65.00% |
| 31 Dec, 21 | 2,881,095 | 948.47% |
| 30 Sep, 21 | 274,791 | 83.31% |
| 30 Jun, 21 | 149,903 | -74.11% |
| 31 Mar, 21 | 579,079 | 1245.13% |
| 31 Dec, 20 | 43,050 | - |
Scopus BioPharma (SCPS) has 76.82K shares outstanding as of 31 Dec 22, down -83.47% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 22 | 0.36% | 7.50% |
| 30 Sep, 22 | 2.20% | 20.93% |
| 30 Jun, 22 | 3.24% | 14.20% |
| 31 Mar, 22 | 4.78% | 1.71% |
| 31 Dec, 21 | 16.70% | 650.36% |
| 30 Sep, 21 | 1.60% | 186.96% |
| 30 Jun, 21 | 0.93% | 6.49% |
| 31 Mar, 21 | 3.78% | 3637.46% |
| 31 Dec, 20 | 0.32% | - |
As of 31 Dec 22, Scopus BioPharma is held by 0.36% institutional shareholders, representing a 7.50% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 22 | - | -100.00% |
| 30 Sep, 22 | 2 | -60.00% |
| 30 Jun, 22 | 5 | -50.00% |
| 31 Mar, 22 | 10 | -16.67% |
| 31 Dec, 21 | 12 | 50.00% |
| 30 Sep, 21 | 8 | 33.33% |
| 30 Jun, 21 | 6 | -76.92% |
| 31 Mar, 21 | 26 | 550.00% |
| 31 Dec, 20 | 4 | - |
- institutional shareholders have increased their position in SCPS stock as of 31 Dec 22 compared to 2 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 22 | - | -100.00% |
| 30 Sep, 22 | 4 | 100.00% |
| 30 Jun, 22 | 2 | - |
| 31 Mar, 22 | 2 | -50.00% |
| 31 Dec, 21 | 4 | 33.33% |
| 30 Sep, 21 | 3 | -40.00% |
| 30 Jun, 21 | 5 | 150.00% |
| 31 Mar, 21 | 2 | - |
| 31 Dec, 20 | - | - |
- institutional shareholders have reduced their position in SCPS stock as of 31 Dec 22 compared to 4 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 22 | 1 | -91.67% | 76,819 | -83.47% | 0.36% | 7.50% | - | -100.00% | - | -100.00% |
| 30 Sep, 22 | 12 | -7.69% | 464,786 | -32.10% | 2.20% | 20.93% | 2 | -60.00% | 4 | 100.00% |
| 30 Jun, 22 | 13 | -23.53% | 684,494 | -32.12% | 3.24% | 14.20% | 5 | -50.00% | 2 | - |
| 31 Mar, 22 | 17 | -15.00% | 1,008,382 | -65.00% | 4.78% | 1.71% | 10 | -16.67% | 2 | -50.00% |
| 31 Dec, 21 | 20 | 81.82% | 2,881,095 | 948.47% | 16.70% | 650.36% | 12 | 50.00% | 4 | 33.33% |
| 30 Sep, 21 | 11 | -8.33% | 274,791 | 83.31% | 1.60% | 186.96% | 8 | 33.33% | 3 | -40.00% |
| 30 Jun, 21 | 12 | -57.14% | 149,903 | -74.11% | 0.93% | 6.49% | 6 | -76.92% | 5 | 150.00% |
| 31 Mar, 21 | 28 | 600.00% | 579,079 | 1245.13% | 3.78% | 3637.46% | 26 | 550.00% | 2 | - |
| 31 Dec, 20 | 4 | - | 43,050 | - | 0.32% | - | 4 | - | - | - |
Scopus BioPharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Scopus BioPharma's stock was made by Greenspan Ira Scott on Nov 26 2021, selling 3,000,000 shares at $4.00 per share (valued at $12.00M). The last insider buy of SCPS was made by Greenspan Ira Scott on Aug 30 2021, buying 110 shares at $4.92 per share (worth $541.20).
Scopus BioPharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2021 | - | 5 | - |
| Q3 2021 | 20 | 1 | 2000.00% |
| Q2 2021 | 1 | 1 | 100.00% |
| Q1 2021 | 15 | 5 | 300.00% |
| Q4 2020 | - | 5 | - |
| Q2 2020 | - | 1 | - |
| Q3 2019 | - | 1 | - |
0 total buy trades, and 5 total sell trades (buy/sell ratio of 0.00%) were made by Scopus BioPharma's insiders, as of Q4 2021.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2021 | - | - | - |
| Q3 2021 | 16 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 15 | - | - |
| Q4 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q3 2019 | - | - | - |
As of Q4 2021, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Scopus BioPharma's stocks.
SCPS Ownership FAQ
Who Owns Scopus BioPharma?
Scopus BioPharma is owned by institutional shareholders (0.36%), insiders (18.69%), and public (80.95%). The largest institutional shareholder of Scopus BioPharma is M&R CAPITAL MANAGEMENT INC (0% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.01% of total shares).
Who are the major institutional shareholders of Scopus BioPharma?
Scopus BioPharma's major institutional shareholders are M&R CAPITAL MANAGEMENT INC. The top five shareholders own together 0% of the company's share outstanding.
How many Scopus BioPharma shareholders are there?
As of Dec 2022, there are 1 institutional shareholders of Scopus BioPharma.
What percentage of Scopus BioPharma is owned by M&R CAPITAL MANAGEMENT INC?
M&R CAPITAL MANAGEMENT INC owns 0 shares of Scopus BioPharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2023).